Renal cell carcinoma and venous tumour thrombus.

Autor:	Bentin JM; Afdeling for Urinvejskirurgi, Center for Kræft og Organsygdomme, Københavns Universitetshospital - Rigshospitalet., Iversen IJ; Afdeling for Hjerte- og Lungekirurgi, Hjertecentret, Københavns Universitetshospital - Rigshospitalet., Rosengaard LB; Afdeling for Bedøvelse, Operation og Intensiv Behandling, Hjertecentret, Københavns Universitetshospital - Rigshospitalet., Thiis JJ; Afdeling for Hjerte- og Lungekirurgi, Hjertecentret, Københavns Universitetshospital - Rigshospitalet., Bagi P; Afdeling for Urinvejskirurgi, Center for Kræft og Organsygdomme, Københavns Universitetshospital - Rigshospitalet.
Jazyk:	dánština
Zdroj:	Ugeskrift for laeger [Ugeskr Laeger] 2024 Jan 01; Vol. 186 (1). Date of Electronic Publication: 2024 Jan 01.
DOI:	10.61409/V06230354
Abstrakt:	Renal cell carcinomas (RCCs) represent 2-3% of cancer cases in Denmark, with increasing incidence. RCCs invading the inferior vena cava (IVC) with tumour thrombus (TT) are associated with poor prognosis. Classification is based on tumour extent in the IVC. Surgical treatment involves radical nephrectomy and thrombectomy, with different approaches depending on TT level. Complications are significant, with a mortality rate of 2-13%. Additional therapies may improve outcomes. This review finds that all patients with RCC and IVC TT should be considered for surgery. (Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu